AXSOME THERAPEUTICS INC. - COMMON STOCK
126.31
17-March-25 13:17:02
15 minutes delayed
Stocks
+4.40
+3.61%
Today's range
121.90 - 126.35
ISIN
N/A
Source
NASDAQ
-
Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20
23 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
04 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today
07 Dec 2023 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7
22 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
21 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
06 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
31 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
24 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors
11 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Third Quarter 2023 Financial Results on November 6
10 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
02 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
21 Sep 2023 06:00:00 By Nasdaq GlobeNewswire
-
07 Sep 2023 06:03:16 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
07 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Second Quarter 2023 Financial Results on August 7
12 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
07 Jul 2023 06:00:53 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Announces Closing of Public Offering of $225 Million of Shares of Common Stock
30 Jun 2023 15:02:39 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock
28 Jun 2023 08:28:25 By Nasdaq GlobeNewswire